WP
BMY icon

Woodline Partners’s Bristol-Myers Squibb BMY Stock Holding History

Woodline Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68M Buy
1,120,638
+51,521
+5% +$3M 0.26% 85
2025
Q4 		$57.7M Buy
1,069,117
+78,866
+8% +$3.79M 0.22% 108
2025
Q3 		$44.7M Buy
990,251
+13,891
+1% +$649K 0.21% 130
2025
Q2 		$45.2M Sell
976,360
-315,255
-24% -$15.5M 0.24% 116
2025
Q1 		$78.8M Sell
1,291,615
-270,007
-17% -$15.7M 0.51% 29
2024
Q4 		$88.3M Buy
1,561,622
+783,466
+101% +$43.8M 0.6% 24
2024
Q3 		$40.3M Buy
778,156
+14,984
+2% +$703K 0.34% 91
2024
Q2 		$31.7M Sell
763,172
-6,082
-0.8% -$272K 0.3% 101
2024
Q1 		$41.7M Buy
769,254
+156
+0% +$7.95K 0.38% 72
2023
Q4 		$39.5M Buy
769,098
+531,618
+224% +$27.9M 0.43% 66
2023
Q3 		$13.8M Buy
237,480
+37,280
+19% +$2.28M 0.16% 179
2023
Q2 		$12.8M Sell
200,200
-61,413
-23% -$4.12M 0.15% 177
2023
Q1 		$18.1M Buy
261,613
+2,943
+1% +$208K 0.25% 116
2022
Q4 		$18.6M Sell
258,670
-9,230
-3% -$696K 0.25% 120
2022
Q3 		$19M Sell
267,900
-582,280
-68% -$42.2M 0.27% 109
2022
Q2 		$65.5M Buy
850,180
+454,610
+115% +$34.6M 1.01% 9
2022
Q1 		$28.9M Hold
395,570
– – 0.47% 61
2021
Q4 		$24.7M Hold
395,570
– – 0.35% 68
2021
Q3 		$23.4M Hold
395,570
– – 0.38% 71
2021
Q2 		$26.4M Sell
395,570
-211,261
-35% -$13.8M 0.49% 51
2021
Q1 		$38.3M Buy
+606,831
New +$37.8M 0.85% 30
2020
Q4 		– Sell
-1,103,742
Closed -$66.5M – 230
2020
Q3 		$66.5M Buy
+1,103,742
New +$66.4M 2.18% 7
2020
Q1 		– Sell
-552,945
Closed -$35.5M – 143
2019
Q4 		$35.5M Buy
+552,945
New +$31.7M 1.45% 24

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodline Partners's BMY Position: Q1 2026 in Review

Woodline Partners increased its Bristol-Myers Squibb (BMY) stake by 4.8% in Q1 2026, buying an estimated $3M and bringing the position to 1,120,638 shares worth $68M. The position accounts for 0.26% of the portfolio, ranked #85.

Woodline Partners first reported a position in BMY in Q4 2019 and has held it in 23 quarters since. The position peaked at $88.3M in Q4 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Woodline Partners held 1,120,638 shares of Bristol-Myers Squibb worth $68M as of Q1 2026.
  • Woodline Partners bought 51,521 Bristol-Myers Squibb shares in Q1 2026, an estimated $3M.
  • Bristol-Myers Squibb made up 0.26% of Woodline Partners's portfolio in Q1 2026, its #85 holding.
  • Woodline Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 23 quarters since.
  • Woodline Partners's Bristol-Myers Squibb position peaked at $88.3M in Q4 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.